1621252-78-5

Basic information

• Product Name: 3-[(4-hydroxy-3-methoxybenzylidene)amino]-2-thioxo-1,3-thiazolidin-4-one
• Synonyms: 3-[(4-hydroxy-3-methoxybenzylidene)amino]-2-thioxo-1,3-thiazolidin-4-one
• CAS NO: 1621252-78-5
• Molecular Formula: C11H10N2O3S2
• Molecular Weight: 282.3387
• Mol File: 1621252-78-5.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-[(4-hydroxy-3-methoxybenzylidene)amino]-2-thioxo-1,3-thiazolidin-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[(4-hydroxy-3-methoxybenzylidene)amino]-2-thioxo-1,3-thiazolidin-4-one(1621252-78-5)
• EPA Substance Registry System: 3-[(4-hydroxy-3-methoxybenzylidene)amino]-2-thioxo-1,3-thiazolidin-4-one(1621252-78-5)

Safety Data

• Hazardous Substances Data: 1621252-78-5(Hazardous Substances Data)

Upstream product

• 1438-16-0 3-aminorhodanine 
• 121-33-5 vanillin 

Relevant articles and documents

The green synthesis and molecular docking of novel N-substituted rhodanines as effective inhibitors for carbonic anhydrase and acetylcholinesterase enzymes

Recently, inhibition effects of enzymes such as acetylcholinesterase (AChE) and carbonic anhydrase (CA) has appeared as a promising approach for pharmacological intervention in a variety of disorders such as epilepsy, Alzheimer's disease and obesity. For this purpose, novel N-substituted rhodanine derivatives (RhAs) were synthesized by a green synthetic approach over one-pot reaction. Following synthesis the novel compounds, RhAs derivatives were tested against AChE and cytosolic carbonic anhydrase I, and II (hCAs I, and II) isoforms. As a result of this study, inhibition constant (Ki) were found in the range of 66.35 ± 8.35 to 141.92 ± 12.63 nM for AChE, 43.55 ± 14.20 to 89.44 ± 24.77 nM for hCA I, and 16.97 ± 1.42 to 64.57 ± 13.27 nM for hCA II, respectively. Binding energies were calculated with docking studies as ?5.969, ?5.981, and ?9.121 kcal/mol for hCA I, hCA II, and AChE, respectively.

Synthesis, antioxidant and cytoprotective evaluation of potential antiatherogenic phenolic hydrazones. A structure-activity relationship insight

A novel series of hydrazones derived from substituted benzaldehydes have been synthesized as potential antiatherogenic agents. Several methods were used for exploring their antioxidant and cytoprotective properties, such as their scavenging effect on 2,2-